RecruitingPhase 1Phase 2NCT07367529

A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

A Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of TQB6411 for Injection in Patients With Advanced Lung Cancer

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Enrollment

465 participants

Start Date

Feb 26, 2026

Study Type

INTERVENTIONAL

Conditions

Advanced Lung Cancer

Summary

To evaluate the efficacy and safety of TQB6411 for Injection in subjects with advanced lung cancer

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called TQB6411 for Injection for people with advanced lung cancer. The study is currently recruiting participants at 38 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTQB6411 for Injection

TQB6411 for Injection is administered every 21 days as a treatment cycle. TQB6411 for injection is administered every 28 days as a treatment cycle.

Locations(38)

Cancer Hospital Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, China

Beijing Chest Hospital，Capital Medical University

Beijing, Beijing Municipality, China

Chongqing University Affiliated Three Gorges Hospital

Chongqing, Chongqing Municipality, China

The first affiliated hospital of Guangzhou medical university

Guangzhou, Guangdong, China

The first affiliated hospital of Guangzhou medical university

Guanzhou, Guangdong, China

Zhongshan City People's Hospital

Zhongshan, Guangdong, China

Guangxi Medical University Cancer Hospital

Nanning, Guangxi, China

Guangxi Medical University Cancer Hospital

Nanning, Guangxi, China

Cangzhou Central hospital

Cangzhou, Hebei, China

Cangzhou Central hospital

Cangzhou, Hebei, China

Harbin Medical University Cancer Hospital

Harbin, Heilongjiang, China

Harbin Medical University Cancer Hospital

Harbin, Heilongjiang, China

Anyang People's Hospital

Anyang, Henan, China

Luoyang Central Hospital (Zhengzhou University Affiliated Luoyang Central Hospital)

Luoyang, Henan, China

Nanyang Second General Hospital

Nanyang, Henan, China

Zhongnan Hospital of Wuhan University

Wuhan, Hubei, China

The Third Xiangya Hospital of Central South University

Changsha, Hunan, China

Jiangsu Provincial Hospital of Traditional Chinese Medicine

Nanjin, Jiangsu, China

Nanjing Drum Tower Hospital

Nanjing, Jiangsu, China

Northern Jiangsu People's Hospital

Yangzhou, Jiangsu, China

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Affiliated Zhongshan Hospital Of dalian University

Dalian, Liaoning, China

Affiliated Zhongshan Hospital Of dalian University

Dalian, Liaoning, China

Liaoning Cancer Research Institute

Shenyang, Liaoning, China

The First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, China

Shandong First Medical University Affiliated Tumor Hospital

Jinan, Shandong, China

Shandong First Medical University Affiliated Tumor Hospital

Jinan, Shandong, China

Linyi cancer Hospital

Linyi, Shandong, China

Shanghai Pulmonary Hospital

Shanghai, Shanghai Municipality, China

Shanghai Pulmonary Hospital

Shanghai, Shanghai Municipality, China

First Hospital of Shangxi Medical University

Taiyuan, Shangxi, China

Shanxi Cancer hospital

Taiyuan, Shanxi, China

Shanxi Cancer hospital

Taiyuan, Shanxi, China

The Second Affiliated Hospital of Air Force Medical University

Xi’an, Shanxi, China

Sichuan cancer hosipital

Chengdu, Sichuan, China

Tianjin Medical University Cancer Institute & Hospital

Tianjin, Tianjin Municipality, China

Sir Run Run Shaw Hospital Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

Taizhou Hospital of Zhejiang Province

Taizhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07367529

Related Trials

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

NCT0689254888 locations

A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer

NCT073092761 location